Rationale for cavernous nerve restorative therapy to preserve erectile function after radical prostatectomy

Urology

Volumn 61, Issue 3, 2003, Pages 491-497

  Burnett, Arthur L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL;

AUTONOMIC NERVE; CLINICAL TRIAL; CONVALESCENCE; CORRELATION ANALYSIS; ERECTILE DYSFUNCTION; HUMAN; INCIDENCE; PENIS ERECTION; PENIS PROSTHESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; REVIEW; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SUPPOSITORY;

EID: 0037334150     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02271-9     Document Type: Review

References (45)

1. Han M., Partin A.W., Pound C.R., et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am. 28:2001;555-565.
2. Zonszein J. Diagnosis and management of endocrine disorders of erectile dysfunction. Urol Clin North Am. 22:1995;789-802.
3. Walsh P.C., Donker P.J. Impotence following radical prostatectomy insight into etiology and prevention . J Urol. 167:2002;1005-1010.
4. Walsh P.C., Lepor H., Eggleston J.C. Radical prostatectomy with preservation of sexual function anatomical and pathological considerations . Prostate. 4:1983;473-485.
5. Walsh P.C., Partin A.W., Epstein J.L. Cancer control and quality of life following anatomical radical retropubic prostatectomy results at 10 years . J Urol. 152:1994;1831-1836.
6. Catalona W.J., Carvalhal G.F., Mager D.E., et al. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol. 162:1999;433-438.
7. Rabbani F., Stapleton A.M.F., Kattan M.W., et al. Factors predicting recovery of erections after radical prostatectomy. J Urol. 164:2000;1929-1934.
8. Walsh P.C., Marschke P., Ricker D., et al. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology. 55:2000;58-61.
9. Lim A.J., Brandon A.H., Fiedler J., et al. Quality of life radical prostatectomy versus radiation therapy for prostate cancer . J Urol. 154:1995;1420-1425.
10. McCammon K.A., Kolm P., Main B., et al. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology. 54:1999;509-516.
11. Gralnek D., Wessells H., Cui H., et al. Differences in sexual function and quality of life after nerve sparing and non-nerve sparing radical retropubic prostatectomy. J Urol. 163:2000;1166-1170.
12. Litwin M.S., Hays R.D., Fink A., et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 273:1995;129-135.
13. Jonler M., Messing E.M., Rhodes P.R., et al. Sequelae of radical prostatectomy. Br J Urol. 74:1994;352-358.
14. Fowler F.J., Barry M.J., Lu-Yao G., et al. Patient-reported complications and follow-up treatment after radical prostatectomy. The national medicare experience 1988-1990 (updated June 1993) . Urology. 42:1993;622-629.
15. Siegel T., Moul J.W., Spevak M., et al. The development of erectile dysfunction in men treated for prostate cancer. J Urol. 165:2001;430-435.
16. Talcott J.A., Rieker P., Clark J.A., et al. Patient-reported symptoms after primary therapy for early prostate cancer results of a prospective cohort study . J Clin Oncol. 16:1998;275-283.
17. Quinlan D.M., Epstein J.I., Carter B.S., et al. Sexual function following radical prostatectomy influence of preservation of neurovascular bundles . J Urol. 145:1991;998-1002.
18. Leandri P., Rossignol G., Gautier J.R., et al. Radical retropubic prostatectomy morbidity and quality of life. Experience with 620 consecutive cases . J Urol. 147:1992;883-887.
19. Robinson J.W., Dufour M.S., Fung T.S. Erectile functioning of men treated for prostate carcinoma. Cancer. 79:1997;538-544.
20. Stanford J.L., Feng Z., Hamilton A.S., et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer. The prostate cancer outcomes study. JAMA. 283:2000;354-360.
21. Feldman H.A., Goldstein I., Hatzichristou D.G., et al. Impotence and its medical and psychosocial correlates results of the Massachusetts Male Aging Study . J Urol. 151:1994;54-61.
22. Rosen R.C., Cappelleri J.C., Smith M.D., et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 11:1999;319-326.
23. Bahnson R.R., Catalona W.J. Papaverine testing of impotent patients following nerve-sparing radical prostatectomy. J Urol. 139:1988;773-774.
24. Breza J., Aboseif S.R., Orvis B.R., et al. Detailed anatomy of penile neurovascular structures surgical significance . J Urol. 141:1989;437-443.
25. Droupy S., Hessel A., Benoît G., et al. Assessment of the functional role of accessory pudendal arteries in erection by transrectal color Doppler ultrasound. J Urol. 162:1999;1987-1991.
26. Polascik T.J., Walsh P.C. Radical retropubic prostatectomy the influence of accessory pudendal arteries on the recovery of sexual function . J Urol. 153:1995;150-152.
27. Aboseif S., Shinohara K., Breza J., et al. Role of penile vascular injury in erectile dysfunction after radical prostatectomy. Br J Urol. 73:1994;75-82.
28. Mulhall J.P., Graydon R.J. The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. Int J Impot Res. 8:1996;91-94.
29. Flanigan K.M., Lauria G., Griffin J.W., et al. Age-related biology and diseases of muscle and nerve. Neurol Clin. 16:1998;659-669.
30. Griffin JW, and Hoffman PN: Degeneration and regeneration in the peripheral nervous system, in Dyck PJ (Ed): Peripheral Neuropathy. Philadelphia, Saunders, 1993, vol 2, pp 361-376.
31. Fraiman M.C., Lepor H., McCullough A.R. Changes in penile morphometrics in men with erectile dysfunction after nerve-sparing radical retropubic prostatectomy. Mol Urol. 3:1999;109-115.
32. Nehra A., Goldstein I., Pabby A., et al. Mechanisms of venous leakage a prospective clinicopathological correlation of corporeal function and structure . J Urol. 156:1996;1320-1329.
33. Podlasek C.A., Gonzalez C.M., Zelner D.J., et al. Analysis of NOS isoform changes in a post radical prostatectomy model of erectile dysfunction. Int J Impot Res. 13:(suppl):2001;S1-S15.
34. Mulhall J.P., Slovick R., Hotaling J., et al. Erectile dysfunction after radical prostatectomy hemodynamic profiles and their correlation with the recovery of erectile function . J Urol. 167:2002;1371-1375.
35. Klein L.T., Miller M.I., Buttyan R., et al. Apoptosis in the rat penis after penile denervation. J Urol. 158:1997;626-630.
36. Nehra A. Medical and surgical advances in the radical prostatectomy patient. Int J Impot Res. 12:(suppl):2000;S47-S52.
37. McCullough A.R. Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am. 28:2001;613-627.
38. Burnett A.L. Oral pharmacotherapy for erectile dysfunction current perspectives . Urology. 54:1999;392-400.
39. Zippe C.D., Jhaveri F.M., Klein E.A., et al. Role of Viagra after radical prostatectomy. Urology. 55:2000;241-245.
40. Lowentritt B.H., Scardino P.T., Miles B.J., et al. Sildenafil citrate after radical retropubic prostatectomy. J Urol. 162:1999;1614-1617.
41. Zagaja G.P., Mhoon D.A., Aikens J.E., et al. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology. 56:2000;631-634.
42. Feng M.I., Huang S., Kaptein J., et al. Effect of sildenafil citrate on post-radical prostatectomy erectile dysfunction. J Urol. 164:2000;1935-1938.
43. Hong E.K., Lepor H., McCullough A.R. Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy (RRP). Int J Impot Res. 11:(suppl):1999;S15-S22.
44. Syriatowicz J.P., Hu D., Walker J.S., et al. Hyperalgesia due to nerve injury role of prostaglandins . Neuroscience. 94:1999;587-594.
45. Moreland R.B., Nehra A., Goldstein I., et al. The role of prostaglandin E as determined by expression of functional prostaglandin E receptors in human corpus cavernosum. J Urol. 161:1999;218A.